Imatinib: hypophosphataemia and bone remodelling inhibition

Author：

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1102, 2006-01, pp. : 4-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Imatinib: Bone marrow aplasia: case report

Reactions Weekly, Vol. 1, Iss. 1431, 2012-01 ,pp. : 23-24

Adis International

Access to resources Recommend Favorite

Imatinib: Fatal bone marrow aplasia: case report

Reactions Weekly, Vol. 1, Iss. 1203, 2008-01 ,pp. : 26-26

Adis International

Access to resources Recommend Favorite

Development of 41Ca-Based Pharmacokinetic Model for the Study of Bone Remodelling in Humans

By Sharma Manju

Clinical Pharmacokinetics, Vol. 50, Iss. 3, 2011-03 ,pp. : 191-199

Adis International

Access to resources Recommend Favorite

Clodronate: mechanisms of action on bone remodelling and clinical use in osteometabolic disorders

By Ghinoi Valentina Brandi Maria Luisa

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 11, 2002-11 ,pp. : 1643-1656

Informa Healthcare

Access to resources Recommend Favorite

Imatinib

By Lyseng-Williamson K. Jarvis B.

Drugs, Vol. 61, Iss. 12, 2001-01 ,pp. : 1765-1774

Adis International

Access to resources Recommend Favorite